Season’s Greetings from Commercial Eyes!
We wish you and your loved ones a holiday filled with peace, joy, and cherished moments – and a New Year that brings health, happiness, and...
Latest Insights
Latest News
ProductLife Group Highlights the Key Role of Artificial Intelligence (AI) in Transforming the Life Sciences Industry
Explore ProductLife Group's latest insights on the transformative impact of AI in life sciences. From drug discovery to pharmacovigilance, learn how AI is shaping a smarter future for pharma. With...
Events & Webinars, Hot Topics, Latest News,
Unlocking the Potential of AI in Healthcare: Key Insights from the BioMelbourne Network Biosymposium
Can you anticipate your competitors’ plans & strategies? Can you predict their reactions to your competitive initiatives? Does your competitor have the capabilities to implement their strategy? Do you know...
Competitive Intelligence in BANI world
Can you anticipate your competitors’ plans & strategies? Can you predict their reactions to your competitive initiatives? Does your competitor have the capabilities to implement their strategy? Do you know...
Navigating the Australian Medical Device Market in 2024
Australia stands out as an attractive market for medical devices due to its mature, well-funded, and stable healthcare system. However, breaking into this market is not without its intricacies and...
Productlife Group Acquires Commercial Eyes, Expanding Its Footprint In The APAC Region
ProductLife Group expands its expertise in APAC through the acquisition of Commercial Eyes, Australia’s leading pharmaceutical and medical device commercialisation company, specialising in regulatory affairs, pharmacovigilance, medical information, quality assurance,...
Leading Healthcare Transformation through Innovative Solutions
Healthcare transformation requires innovative solutions. Through our Service Blueprinting work, we align people, process, and tech to measure and improve health and commercial outcomes. Read more about how Commercial Eyes...
12 Insights from the Recent Australian Digital Health Blueprint and Action Plan Launch
In December 2023, the Australian Federal Department of Health and Aged Care released their digital health blueprint and action plan. Commercial Eyes has identified 12 insights that have short- and...
Unlocking the Power of Transparency: Competitive Intelligence and the Birth of TRoVE (TRansfer of ValuE)
At Commercial Eyes, we are dedicated to staying at the forefront of the pharmaceutical and healthcare industry by developing innovative tools and frameworks that provide valuable insights for our clients. Our...
Extension to TGA Transition Periods for Reclassified Devices and Patient-Matched Devices
The Therapeutic Goods Administration (TGA) recently announced that they have received Government approval to extend the transition period affecting most reclassified devices, as well as patient-matched devices, extending the deadline...
Commercial Eyes Appoints New General Manager
We are excited to announce Tanya van der Wall as our new General Manager. With her extensive experience and deep understanding of the industry, Tanya will lead our expert team...
Significant TGA Fee Increases for Medical Devices in FY24
The Therapeutic Goods Administration (TGA) have released its consultation paper on the proposed fees & charges model for the 2023-24 Financial...